Altre lingue Insmed Incorporated

Azioni

INSM

US4576693075

Tempo reale stimato Cboe BZX Altri mercati azionari 18:03:47 26/04/2024			Variaz. 5gg	Var. 1 gen.
24,82 ^USD	-0,40%		+1,73%	-20,17%

23/04	INSMED INCORPORATED : Truist Securities rimane Buy	ZM
11/04	INSMED INCORPORATED : giudizio positivo da Barclays	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024	25/04
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	08/04
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/04
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference	28/03
Insmed Incorporated to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference	27/03
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)	06/03
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	05/03
Actress Jane Seymour and Insmed Raise Awareness of 'Unseenism' and Empower People to Speak Up When It Comes to Their Health	29/02
Insmed To Present at Three March Conferences	29/02
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health	28/02
Insmed's Q4 Loss Widens, Revenue Rises	22/02
Insmed: Q4 Earnings Snapshot	22/02
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update	22/02
Insmed Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Insmed Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Insmed Incorporated Reiterates Sales Guidance for the Full-Year 2024	22/02
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024	08/02
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	02/02
Insmed Insider Sold Shares Worth $620,089, According to a Recent SEC Filing	05/01
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference	05/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Insmed Incorporated

Azioni

INSM

US4576693075

Altre lingue

Filtri